A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Clinical trial NCT02266745 · UNKNOWN

Trial details

NCT number: NCT02266745
Sponsor: Promontory Therapeutics Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors CRPC mCRPC Metastatic Castrate-resistant Prostate Cancer PT-112 Prostatic Neoplasms Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site

Start date: 2014-07-01
Primary completion: 2024-08-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.